Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
19.3M
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
106M
-
Shares change
-
+6.15M
-
Total reported value, excl. options
-
$688M
-
Value change
-
+$42.2M
-
Put/Call ratio
-
0
-
Number of buys
-
36
-
Number of sells
-
-34
-
Price
-
$6.52
Significant Holders of Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) as of Q2 2022
89 filings reported holding LYEL - Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share as of Q2 2022.
Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 106M shares
.
Largest 10 shareholders include MWG Management Ltd. (20.2M shares), Apoletto Ltd (15.1M shares), Foresite Capital Management IV, LLC (13.3M shares), VANGUARD GROUP INC (10.6M shares), BlackRock Inc. (10M shares), Alphabet Inc. (5.87M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.33M shares), MIC Capital Management UK LLP (3.06M shares), SC CHINA HOLDING Ltd (3.05M shares), and FMR LLC (2.8M shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.